Explore more publications!
Healthcare Weekly Jamaica
Got News to Share?

Healthcare Weekly Jamaica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Weekly Jamaica.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 4, 2026

H1 Named to the 2026 DHNY Hall of Fame After Five Years of Recognition
Feb. 4, 2026

H1 Named to the 2026 DHNY Hall of Fame After Five Years of Recognition

Indeterminate GlobeNewswire
INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
Feb. 4, 2026

INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth

Indeterminate GlobeNewswire
JUST SALAD EXPANDS IN BROOKLYN, NEW YORK
Feb. 4, 2026

JUST SALAD EXPANDS IN BROOKLYN, NEW YORK

Indeterminate GlobeNewswire
Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer
Feb. 4, 2026

Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

Indeterminate GlobeNewswire
GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights
Feb. 4, 2026

GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights

Indeterminate GlobeNewswire
Control the Stack, Control the Future: The New Era of Supply-Chain Power
Feb. 4, 2026

Control the Stack, Control the Future: The New Era of Supply-Chain Power

Indeterminate GlobeNewswire
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
Feb. 4, 2026

Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

Indeterminate GlobeNewswire
Revolo to Present at the 2026 AAAAI Annual Meeting
Feb. 4, 2026

Revolo to Present at the 2026 AAAAI Annual Meeting

Indeterminate GlobeNewswire
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
Feb. 4, 2026

Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

Indeterminate GlobeNewswire
Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor
Feb. 4, 2026

Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor

Indeterminate GlobeNewswire
R1 Awarded ‘Best in KLAS’ Across Multiple RCM Categories for 2026
Feb. 4, 2026

R1 Awarded ‘Best in KLAS’ Across Multiple RCM Categories for 2026

Indeterminate GlobeNewswire
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
Feb. 4, 2026

RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting

Indeterminate GlobeNewswire
NewGen and Evident Capital Successfully Activate Commitment Campaign for Inaugural Tokenized Real Estate Bond, Delivering on Cross-Border Real World Asset Financing Strategy
Feb. 4, 2026

NewGen and Evident Capital Successfully Activate Commitment Campaign for Inaugural Tokenized Real Estate Bond, Delivering on Cross-Border Real World Asset Financing Strategy

Indeterminate GlobeNewswire
Nextech Wins 2026 Best in KLAS for Ambulatory Ophthalmology Solutions
Feb. 4, 2026

Nextech Wins 2026 Best in KLAS for Ambulatory Ophthalmology Solutions

Indeterminate GlobeNewswire
Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas
Feb. 4, 2026

Balt’s Squid™ Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas

Indeterminate GlobeNewswire
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Feb. 4, 2026

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

Indeterminate GlobeNewswire
Ahold Delhaize USA and Circana Partner to Advance Nutritious Choices Through Guiding Stars Data Insights
Feb. 4, 2026

Ahold Delhaize USA and Circana Partner to Advance Nutritious Choices Through Guiding Stars Data Insights

Indeterminate GlobeNewswire
CytomX Therapeutics to Present at Upcoming February Conferences
Feb. 4, 2026

CytomX Therapeutics to Present at Upcoming February Conferences

Indeterminate GlobeNewswire
Stryker declares an $0.88 per share quarterly dividend
Feb. 4, 2026

Stryker declares an $0.88 per share quarterly dividend

Indeterminate GlobeNewswire
NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
Feb. 4, 2026

NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions